FAC
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for FAC, covering 2019-07-12 to 2021-09-22. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 [Phase 2]